Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
1,812 rows where has_cryoEM = 0, surface_class = "B_cargo" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total
tier 1
- Tier 1.5 · 1,812 ✖
surface_class 1
- B_cargo · 1,812 ✖
has_cryoEM 1
- - · 1,812 ✖
has_activation_state_pdb_pair 1
- 0 1,812
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P14136 | GFAP | Glial fibrillary acidic protein | Tier 1.5 | 0.761 | 1 | B_cargo | 1 | 80.0 | 0 | 0 | 1 | 4 | 42022738, 40983220, 27924617, 27399849 | 1 | Alexander disease | 0.8713727112153956 | ||
| P15848 | ARSB | Arylsulfatase B | Tier 1.5 | 0.761 | 1 | B_cargo | 1 | 93.12 | 0 | 0 | 0 | 0 | 1 | mucopolysaccharidosis type 6 | 0.8708405439406184 | |||
| P54802 | NAGLU | Alpha-N-acetylglucosaminidase | Tier 1.5 | 0.761 | 1 | B_cargo | 1 | 96.75 | 0 | 0 | 0 | 0 | 1 | mucopolysaccharidosis type 3B | 0.8688752515463204 | |||
| P00480 | OTC | Ornithine transcarbamylase, mitochondrial | Tier 1.5 | 0.76 | 1 | B_cargo | 4 | 92.19 | 0 | 0 | 1 | 71 | 42031033, 41819402, 41207276, 41033028, 40970979, 40801924, 40719766, 40644866, 40602786, 40187287, 40064103, 40015047, 39904249, 39644528, 39571486, 39275399, 39030014, 38504447, 38193253, 37459789, 37364386, 37103619, 36891736, 36618689, 36454704, 36403375, 35884270, 35672499, 35006795, 34973550, 34821674, 34684942, 34152736, 33812186, 33035887, 32862845, 32768827, 32674777, 31673790, 31580049, 31325751, 31016392, 30837641, 30778448, 30594079, 30426224, 30202432, 30128033, 29937498, 28578167 | 1 | ornithine carbamoyltransferase deficiency | 0.8675763935672858 | ||
| P49748 | ACADVL | Very long-chain acyl-CoA dehydrogenase, mitochondrial | Tier 1.5 | 0.76 | 1 | B_cargo | 3 | 90.25 | 0 | 0 | 0 | 0 | 1 | very long chain acyl-CoA dehydrogenase deficiency | 0.8655785842544526 | |||
| P11532 | DMD | Dystrophin | Tier 1.5 | 0.76 | 1 | B_cargo | 6 | 76.38 | 0 | 0 | 1 | 32 | 41983899, 41503480, 41083485, 40396427, 39910928, 39469668, 38050701, 37765072, 37261868, 34876524, 34693888, 34440571, 34075115, 33617542, 32592467, 28315675, 28252048, 27530235, 27173731, 26594036, 26163061, 26039989, 21838691, 20962041, 17011811, 38448545 | 1 | Duchenne muscular dystrophy | 0.865885140119287 | ||
| Q01968 | OCRL | Inositol polyphosphate 5-phosphatase OCRL | Tier 1.5 | 0.759 | 1 | B_cargo | 5 | 82.56 | 0 | 0 | 0 | 0 | 1 | oculocerebrorenal syndrome | 0.8639646099557533 | |||
| P30566 | ADSL | Adenylosuccinate lyase | Tier 1.5 | 0.756 | 1 | B_cargo | 4 | 96.56 | 0 | 0 | 0 | 0 | 1 | adenylosuccinate lyase deficiency | 0.8537075354730899 | |||
| P35914 | HMGCL | Hydroxymethylglutaryl-CoA lyase, mitochondrial | Tier 1.5 | 0.755 | 1 | B_cargo | 4 | 92.0 | 0 | 0 | 0 | 0 | 1 | 3-hydroxy-3-methylglutaric aciduria | 0.84972741897364 | |||
| P51648 | ALDH3A2 | Aldehyde dehydrogenase family 3 member A2 | Tier 1.5 | 0.755 | 1 | B_cargo | 1 | 96.62 | 0 | 0 | 0 | 0 | 1 | Sjögren-Larsson syndrome | 0.8498976178886021 | |||
| P35475 | IDUA | Alpha-L-iduronidase | Tier 1.5 | 0.755 | 1 | B_cargo | 11 | 94.75 | 0 | 0 | 1 | 1 | 18838694 | 1 | Scheie syndrome | 0.8500187612858606 | ||
| P50336 | PPOX | Protoporphyrinogen oxidase | Tier 1.5 | 0.755 | 1 | B_cargo | 3 | 95.31 | 0 | 0 | 0 | 0 | 1 | variegate porphyria | 0.8511493920751063 | |||
| P48637 | GSS | Glutathione synthetase | Tier 1.5 | 0.754 | 1 | B_cargo | 2 | 94.94 | 0 | 0 | 1 | 1 | 24296062 | 1 | Glutathione synthetase deficiency | 0.8480115629745476 | ||
| P36871 | PGM1 | Phosphoglucomutase-1 | Tier 1.5 | 0.753 | 1 | B_cargo | 16 | 97.12 | 0 | 0 | 0 | 0 | 1 | PGM1-congenital disorder of glycosylation | 0.843931261346685 | |||
| O95571 | ETHE1 | Persulfide dioxygenase ETHE1, mitochondrial | Tier 1.5 | 0.752 | 1 | B_cargo | 1 | 92.88 | 0 | 0 | 0 | 0 | 1 | ethylmalonic encephalopathy | 0.8389957647020829 | |||
| P50897 | PPT1 | Palmitoyl-protein thioesterase 1 | Tier 1.5 | 0.752 | 1 | B_cargo | 1 | 91.69 | 0 | 0 | 1 | 2 | 33112630 | 1 | neuronal ceroid lipofuscinosis 1 | 0.8400332147230634 | ||
| P50416 | CPT1A | Carnitine O-palmitoyltransferase 1, liver isoform | Tier 1.5 | 0.751 | 1 | B_cargo | 1 | 92.44 | 0 | 0 | 1 | 1 | 29325019 | 1 | carnitine palmitoyl transferase 1A deficiency | 0.8360102017303558 | ||
| P54886 | ALDH18A1 | Delta-1-pyrroline-5-carboxylate synthase | Tier 1.5 | 0.75 | 1 | B_cargo | 1 | 84.19 | 0 | 0 | 0 | 0 | 1 | ALDH18A1-related de Barsy syndrome | 0.8337004817329543 | |||
| P48728 | AMT | Aminomethyltransferase, mitochondrial | Tier 1.5 | 0.749 | 1 | B_cargo | 2 | 93.69 | 0 | 0 | 1 | 6 | 41360349, 38751431, 36935143, 32969502, 32779681, 32062632 | 1 | glycine encephalopathy | 0.8307194416875259 | ||
| Q9H0F7 | ARL6 | ADP-ribosylation factor-like protein 6 | Tier 1.5 | 0.749 | 1 | B_cargo | 1 | 94.69 | 0 | 0 | 0 | 0 | 1 | Bardet-Biedl syndrome | 0.831055560105815 | |||
| P02538 | KRT6A | Keratin, type II cytoskeletal 6A | Tier 1.5 | 0.748 | 1 | B_cargo | 1 | 66.31 | 0 | 0 | 0 | 0 | 1 | pachyonychia congenita | 0.8265917804295808 | |||
| P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | Tier 1.5 | 0.748 | 1 | B_cargo | 1 | 91.94 | 0 | 0 | 0 | 0 | 1 | succinyl-CoA:3-ketoacid CoA transferase deficiency | 0.8271377770408165 | |||
| Q8IWV7 | UBR1 | E3 ubiquitin-protein ligase UBR1 | Tier 1.5 | 0.748 | 1 | B_cargo | 5 | 84.69 | 0 | 0 | 0 | 0 | 1 | Johanson-Blizzard syndrome | 0.8277473176517505 | |||
| P12955 | PEPD | Xaa-Pro dipeptidase | Tier 1.5 | 0.747 | 1 | B_cargo | 21 | 97.44 | 0 | 0 | 0 | 0 | 1 | prolidase deficiency | 0.8227965856258603 | |||
| Q15833 | STXBP2 | Syntaxin-binding protein 2 | Tier 1.5 | 0.747 | 1 | B_cargo | 1 | 90.0 | 0 | 0 | 0 | 0 | 1 | Familial hemophagocytic lymphohistiocytosis | 0.8239664182555839 | |||
| Q14739 | LBR | Delta(14)-sterol reductase LBR | Tier 1.5 | 0.746 | 1 | B_cargo | 1 | 76.62 | 0 | 0 | 0 | 0 | 1 | Greenberg dysplasia | 0.8198252534620432 | |||
| P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | Tier 1.5 | 0.746 | 1 | B_cargo | 1 | 91.69 | 0 | 0 | 0 | 0 | 1 | glycogen storage disease VII | 0.8199812991737021 | |||
| P38571 | LIPA | Lysosomal acid lipase/cholesteryl ester hydrolase | Tier 1.5 | 0.745 | 1 | B_cargo | 1 | 91.56 | 0 | 0 | 0 | 0 | 1 | cholesteryl ester storage disease | 0.8176913717992665 | |||
| Q14938 | NFIX | Nuclear factor 1 X-type | Tier 1.5 | 0.745 | 1 | B_cargo | 3 | 61.62 | 0 | 0 | 0 | 0 | 1 | Malan overgrowth syndrome | 0.8156080181042044 | |||
| P02549 | SPTA1 | Spectrin alpha chain, erythrocytic 1 | Tier 1.5 | 0.745 | 1 | B_cargo | 3 | 76.38 | 0 | 0 | 0 | 0 | 1 | elliptocytosis 2 | 0.8153311905916062 | |||
| P04080 | CSTB | Cystatin-B | Tier 1.5 | 0.744 | 1 | B_cargo | 3 | 95.56 | 0 | 0 | 0 | 0 | 1 | Unverricht-Lundborg disease | 0.8143874694671263 | |||
| Q15738 | NSDHL | Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating | Tier 1.5 | 0.744 | 1 | B_cargo | 2 | 88.62 | 0 | 0 | 0 | 0 | 1 | CHILD syndrome | 0.81209434191833 | |||
| O95822 | MLYCD | Malonyl-CoA decarboxylase, mitochondrial | Tier 1.5 | 0.744 | 1 | B_cargo | 2 | 89.94 | 0 | 0 | 0 | 0 | 1 | malonic aciduria | 0.8148554714603661 | |||
| Q01433 | AMPD2 | AMP deaminase 2 | Tier 1.5 | 0.744 | 1 | B_cargo | 4 | 80.69 | 0 | 0 | 0 | 0 | 1 | pontocerebellar hypoplasia type 9 | 0.8149450703818453 | |||
| Q9UGM6 | WARS2 | Tryptophan--tRNA ligase, mitochondrial | Tier 1.5 | 0.743 | 1 | B_cargo | 1 | 89.75 | 0 | 0 | 0 | 0 | 1 | neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures | 0.8094386747017313 | |||
| P02533 | KRT14 | Keratin, type I cytoskeletal 14 | Tier 1.5 | 0.743 | 1 | B_cargo | 2 | 73.25 | 0 | 0 | 0 | 0 | 1 | epidermolysis bullosa simplex 1A, generalized severe | 0.8088593947918921 | |||
| Q16836 | HADH | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | Tier 1.5 | 0.742 | 1 | B_cargo | 12 | 96.81 | 0 | 0 | 0 | 0 | 1 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | 0.8054501080547742 | |||
| Q9UJS0 | SLC25A13 | Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial | Tier 1.5 | 0.742 | 1 | B_cargo | 1 | 82.31 | 0 | 0 | 0 | 0 | 1 | neonatal intrahepatic cholestasis due to citrin deficiency | 0.8051027586554986 | |||
| O95202 | LETM1 | Mitochondrial proton/calcium exchanger protein | Tier 1.5 | 0.742 | 1 | B_cargo | 2 | 66.56 | 0 | 0 | 0 | 0 | 1 | neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction | 0.8053871863850453 | |||
| P09936 | UCHL1 | Ubiquitin carboxyl-terminal hydrolase isozyme L1 | Tier 1.5 | 0.741 | 1 | B_cargo | 14 | 93.62 | 0 | 0 | 1 | 2 | 30863411 | 1 | early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome | 0.8048623975346616 | ||
| P51610 | HCFC1 | Host cell factor 1 | Tier 1.5 | 0.741 | 1 | B_cargo | 11 | 46.41 | 0 | 0 | 0 | 0 | 1 | methylmalonic acidemia with homocystinuria, type cblX | 0.8025576540875302 | |||
| Q16854 | DGUOK | Deoxyguanosine kinase, mitochondrial | Tier 1.5 | 0.741 | 1 | B_cargo | 1 | 86.06 | 0 | 0 | 0 | 0 | 1 | mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | 0.8027927477832228 | |||
| Q6NUK1 | SLC25A24 | Mitochondrial adenyl nucleotide antiporter SLC25A24 | Tier 1.5 | 0.74 | 1 | B_cargo | 3 | 81.31 | 0 | 0 | 1 | 1 | 41871245 | 1 | Fontaine progeroid syndrome | 0.7984507086824493 | ||
| Q9BT40 | INPP5K | Inositol polyphosphate 5-phosphatase K | Tier 1.5 | 0.738 | 1 | B_cargo | 1 | 88.38 | 0 | 0 | 0 | 0 | 1 | muscular dystrophy, congenital, with cataracts and intellectual disability | 0.7921804970122728 | |||
| O15357 | INPPL1 | Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 | Tier 1.5 | 0.738 | 1 | B_cargo | 11 | 69.25 | 0 | 0 | 0 | 0 | 1 | opsismodysplasia | 0.7942030158613098 | |||
| P98175 | RBM10 | RNA-binding protein 10 | Tier 1.5 | 0.738 | 1 | B_cargo | 6 | 59.97 | 0 | 0 | 0 | 0 | 1 | TARP syndrome | 0.7926540744990629 | |||
| Q5JTZ9 | AARS2 | Alanine--tRNA ligase, mitochondrial | Tier 1.5 | 0.737 | 1 | B_cargo | 3 | 87.88 | 0 | 0 | 0 | 0 | 1 | combined oxidative phosphorylation defect type 8 | 0.790456486417183 | |||
| P07384 | CAPN1 | Calpain-1 catalytic subunit | Tier 1.5 | 0.735 | 1 | B_cargo | 5 | 89.94 | 0 | 0 | 0 | 0 | 1 | Autosomal recessive spastic paraplegia type 76 | 0.7826099721448625 | |||
| Q13586 | STIM1 | Stromal interaction molecule 1 | Tier 1.5 | 0.735 | 1 | B_cargo | 6 | 67.81 | 0 | 0 | 0 | 0 | 1 | myopathy, tubular aggregate, 1 | 0.7836768834970178 | |||
| Q8TDI0 | CHD5 | ATP-dependent chromatin remodeler CHD5 | Tier 1.5 | 0.735 | 1 | B_cargo | 1 | 62.0 | 0 | 0 | 0 | 0 | 1 | parenti-mignot neurodevelopmental syndrome | 0.7837472852063317 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;